Moji Awogbade
Overview
Explore the profile of Moji Awogbade including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
426
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oteng-Ntim E, Oakley L, Robinson V, Brien S, Joseph J, Sharif J, et al.
Blood Adv
. 2024 Jul;
8(16):4359-4369.
PMID: 38954844
Serial prophylactic exchange blood transfusion (SPEBT) is increasingly used in sickle cell disease (SCD) pregnancy, despite a lack of robust evidence. The Transfusion Antenatally in Pregnant Women with Sickle Cell...
2.
Clayden J, Stotesbury H, Kawadler J, Slee A, Klbel M, Saunders D, et al.
Blood Adv
. 2022 Aug;
7(11):2297-2308.
PMID: 35947137
In sickle cell disease, the relative importance of reduced hemoglobin (Hb) and peripheral oxygen saturation on brain structure remains uncertain. We applied graph-theoretical analysis to diffusion magnetic resonance imaging data...
3.
Hood A, Kolbel M, Stotesbury H, Kawadler J, Slee A, Inusa B, et al.
Front Psychol
. 2021 Oct;
12:681137.
PMID: 34594262
Sickle cell disease (SCD) refers to a group of inherited blood disorders with considerable morbidity that causes severe pain, reduces life expectancy, and requires significant self-management. Acute painful episodes are...
4.
Telfer P, de la Fuente J, Sohal M, Brown R, Eleftheriou P, Roy N, et al.
Haematologica
. 2020 Oct;
105(11):2651-2654.
PMID: 33054122
No abstract available.
5.
Willis J, Awogbade M, Howard J, Breen C, Abbas A, Harber M, et al.
PLoS One
. 2020 Aug;
15(8):e0236998.
PMID: 32790687
There are over 12,000 people with sickle cell disease (SCD) in the UK, and 4-12% of patients who develop Sickle Cell Nephropathy (SCN) progress to End Stage Renal Disease (ESRD)....
6.
Oakley L, Awogbade M, Brien S, Briley A, Chorozoglou M, Drasar E, et al.
Trials
. 2020 Apr;
21(1):347.
PMID: 32312326
Background: Pregnancies in women with sickle cell disease (SCD) are associated with a higher risk of sickle and pregnancy complications. Limited options exist for treating SCD during pregnancy. Serial prophylactic...
7.
Brewin J, Crowley M, Kesse-Adu R, Stuart-Smith S, Awogbade M, Howard J
Br J Haematol
. 2020 Mar;
189(5):e198-e200.
PMID: 32207154
No abstract available.
8.
Kawadler J, Slee A, Stotesbury H, Koelbel M, Balfour P, Saunders D, et al.
Br J Haematol
. 2019 Mar;
186(2):360-363.
PMID: 30836440
No abstract available.
9.
Howard J, Hemmaway C, Telfer P, Layton D, Porter J, Awogbade M, et al.
Blood
. 2019 Jan;
133(17):1865-1875.
PMID: 30655275
New treatments directly targeting polymerization of sickle hemoglobin (HbS), the proximate event in the pathophysiology of sickle cell disease (SCD), are needed to address the severe morbidity and early mortality...
10.
Farook M, Awogbade M, Somasundaram K, Reichert I, Li P
Int Orthop
. 2018 Jun;
43(2):293-298.
PMID: 29907913
Background: Sickle cell disease (SCD) is a multisystem disease, and the predominant articular manifestation is osteonecrosis (ON). Total hip arthroplasty (THA) is technically challenging, and the complication rates are high....